Rehmann Capital Advisory Group’s Genmab GMAB Stock Holding History

Rehmann Capital Advisory Group’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$810	Buy	+40	New	+$788	﹤0.01%	1587

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Rehmann Capital Advisory Group's GMAB Position: Q3 2019 in Review

Rehmann Capital Advisory Group opened a new position in Genmab (GMAB) in Q3 2019: 40 shares worth $810. The stake represents ﹤0.01% of the portfolio and ranks #1587 among its holdings.

97 funds tracked by Wall St. Rank hold GMAB as of Q3 2019.

Rehmann Capital Advisory Group held 40 shares of Genmab worth $810 as of Q3 2019.
Genmab was a new Rehmann Capital Advisory Group position in Q3 2019.
Genmab made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1587 holding.
97 funds tracked by Wall St. Rank held Genmab as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.